[11C]Harmine Binding to Brain Monoamine Oxidase A: Test-Retest Properties and Noninvasive Quantification.

Purpose: Inhibition of the isoform A of monoamine oxidase (MAO-A), a mitochondrial enzyme catalyzing deamination of monoamine neurotransmitters, is useful in treatment of depression and anxiety disorders. [11C]harmine, a MAO-A PET radioligand, has been used to study mood disorders and antidepressant...

Descripción completa

Detalles Bibliográficos
Publicado en:Molecular Imaging & Biology Vol. 20; no. 4; pp. 667 - 682
Autores principales: Zanderigo, Francesca, D’Agostino, Alexandra E., Joshi, Nandita, Schain, Martin, Kumar, Dileep, Parsey, Ramin V., DeLorenzo, Christine, Mann, J. John, D'Agostino, Alexandra E
Formato: research tables/charts Journal Article
Publicado: Springer Nature Aug2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=130645758&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 130645758
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15361632
        KJU
      jtl: Molecular Imaging & Biology
      issn: 15361632
      maglogo: N
    pubinfo:
      dt: Aug2018
      vid: 20
      iid: 4
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        130645758
        130645758
        NLM29423903
        130645758
        10.1007/s11307-018-1165-3
        NLM29423903
        130645758
      ppf: 667
      ppct: 15
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: [11C]Harmine Binding to Brain Monoamine Oxidase A: Test-Retest Properties and Noninvasive Quantification.
      aug:
        au:
          Zanderigo, Francesca
          D’Agostino, Alexandra E.
          Joshi, Nandita
          Schain, Martin
          Kumar, Dileep
          Parsey, Ramin V.
          DeLorenzo, Christine
          Mann, J. John
          D'Agostino, Alexandra E
        affil: Department of Psychiatry, Columbia University, 1051 Riverside Drive, 10032, New York, NY, USA
      sug:
        subj:
          Radioisotopes
          Brain
          Alkaloids
          Oxidoreductases Metabolism
          Aged
          Adolescence
          Time Factors
          Alkaloids Pharmacokinetics
          Adult
          Radioisotopes Blood
          Young Adult
          Middle Age
          Male
          Human
          Aged: 65+ years
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Male
      ab: Purpose: Inhibition of the isoform A of monoamine oxidase (MAO-A), a mitochondrial enzyme catalyzing deamination of monoamine neurotransmitters, is useful in treatment of depression and anxiety disorders. [11C]harmine, a MAO-A PET radioligand, has been used to study mood disorders and antidepressant treatment. However, [11C]harmine binding test-retest characteristics have to date only been partially investigated. Furthermore, since MAO-A is ubiquitously expressed, no reference region is available, thus requiring arterial blood sampling during PET scanning. Here, we investigate [11C]harmine binding measurements test-retest properties; assess effects of using a minimally invasive input function estimation on binding quantification and repeatability; and explore binding potentials estimation using a reference region-free approach.Procedures: Quantification of [11C]harmine distribution volume (VT) via kinetic models and graphical analyses was compared based on absolute test-retest percent difference (TRPD), intraclass correlation coefficient (ICC), and identifiability. The optimal procedure was also used with a simultaneously estimated input function in place of the measured curve. Lastly, an approach for binding potentials quantification in absence of a reference region was evaluated.Results: [11C]harmine VT estimates quantified using arterial blood and kinetic modeling showed average absolute TRPD values of 7.7 to 15.6 %, and ICC values between 0.56 and 0.86, across brain regions. Using simultaneous estimation (SIME) of input function resulted in VT estimates close to those obtained using arterial input function (r = 0.951, slope = 1.073, intercept = - 1.037), with numerically but not statistically higher test-retest difference (range 16.6 to 22.0 %), but with overall poor ICC values, between 0.30 and 0.57.Conclusions: Prospective studies using [11C]harmine are possible given its test-retest repeatability when binding is quantified using arterial blood. Results with SIME of input function show potential for simplifying data acquisition by replacing arterial catheterization with one arterial blood sample at 20 min post-injection. Estimation of [11C]harmine binding potentials remains a challenge that warrants further investigation.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N